Interferon-Inducible p200-Family Proteins as Novel Sensors of Cytoplasmic DNA: Role in Inflammation and Autoimmunity

被引:98
作者
Choubey, Divaker [1 ,2 ]
Duan, Xin [1 ]
Dickerson, Eric [1 ]
Ponomareva, Larissa [1 ,2 ]
Panchanathan, Ravichandran [1 ,2 ]
Shen, Hui [1 ,2 ]
Srivastava, Ratika [1 ]
机构
[1] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA
[2] Cincinnati VA Med Ctr, Res Serv, Cincinnati, OH USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; TUMOR-SUPPRESSOR PROTEIN; LUPUS-LIKE DISEASE; I-INTERFERON; INNATE IMMUNITY; HIN-200; FAMILY; P202; PROTEIN; BINDING-PROPERTIES; ADAPTIVE IMMUNITY; ACTIVATABLE GENE;
D O I
10.1089/jir.2009.0096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deregulated innate immune responses that result in increased levels of type I interferons (IFNs) and stimulation of IFN-inducible genes are thought to contribute to chronic inflammation and autoimmunity. One family of IFN-inducible genes is the Ifi200 family, which includes the murine (eg, Ifi202a, Ifi202b, Ifi203, Ifi204, Mndal, and Aim2) and human (eg, IFI16, MNDA, IFIX, and AIM2) genes. Genes in the family encode structurally related proteins (the p200-family proteins), which share at least one partially conserved repeat of 200-amino acid (200-AA) residues. Consistent with the presence of 2 consecutive oligonucleotide/oligosaccharide-binding folds in the repeat, the p200-family proteins can bind to DNA. Additionally, these proteins (except the p202 proteins) also contain a pyrin (PYD) domain in the N-terminus. Increased expression of p202 proteins in certain strains of female mice is associated with lupus-like disease. Interestingly, only the Aim2 protein is conserved between the mouse and humans. Several recent studies have provided evidence that the Aim2 and p202 proteins can recognize DNA in cytoplasm and the Aim2 protein upon sensing DNA can form a caspase-1-activating inflammasome. In this review, we discuss how the ability of p200-family proteins to sense cytoplasmic DNA may contribute to the development of chronic inflammation and associated diseases.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 83 条
[1]   The HIN domain of IFI-200 proteins consists of two OB folds [J].
Albrecht, M ;
Choubey, D ;
Lengauer, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (03) :679-687
[2]   Apoptotic molecular machinery: Vastly increased complexity in vertebrates revealed by genome comparisons [J].
Aravind, L ;
Dixit, VM ;
Koonin, EV .
SCIENCE, 2001, 291 (5507) :1279-+
[3]   The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation [J].
Asefa, B ;
Klarmann, KD ;
Copeland, NG ;
Gilbert, DJ ;
Jenkins, NA ;
Keller, JR .
BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) :155-167
[4]   TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity [J].
Baccala, Roberto ;
Hoebe, Kasper ;
Kono, Dwight H. ;
Beutler, Bruce ;
Theofilopoulos, Argyrios N. .
NATURE MEDICINE, 2007, 13 (05) :543-551
[5]   Sensors of the innate immune system: their mode of action [J].
Baccala, Roberto ;
Gonzalez-Quintial, Rosana ;
Lawson, Brian R. ;
Stern, Michael E. ;
Kono, Dwight H. ;
Beutler, Bruce ;
Theofilopoulos, Argyrios N. .
NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (08) :448-456
[6]   The emerging role of interferon in human systemic lupus erythematosus [J].
Baechler, EC ;
Gregersen, PK ;
Behrens, TI .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (06) :801-807
[7]   Autoimmunity through cytokine-induced dendritic cell activation [J].
Banchereau, J ;
Pascual, V ;
Palucka, AK .
IMMUNITY, 2004, 20 (05) :539-550
[8]   Type I interferon in systemic lupus erythematosus and other autoimmune diseases [J].
Banchereau, Jacques ;
Pascual, Virginia .
IMMUNITY, 2006, 25 (03) :383-392
[9]   From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold [J].
Bochkarev, A ;
Bochkareva, E .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2004, 14 (01) :36-42
[10]   Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice [J].
Bolland, Silvia ;
Garcia-Sastre, Adolfo .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (08) :1647-1651